Skip to Main Content

Advertisement

Skip Nav Destination

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Blood Adv (2020) 4 (13): 3072–3084.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement